<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor gene 'mutated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>' (MCC) is silenced through promoter methylation in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and has been implicated as a regulator of the nuclear factor kappa B (NFκB) pathway </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, we aimed to determine whether MCC modulates NFκB activation in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: NFκB activation was assessed using luciferase reporter assays in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells in vitro </plain></SENT>
<SENT sid="3" pm="."><plain>MCC methylation was analysed in <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumour</z:e> specimens from patients with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Re-expression of MCC reduced NFκB-dependent transcription in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha (TNFα)- or <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> (LPS)-stimulated cells </plain></SENT>
<SENT sid="5" pm="."><plain>Conversely, knockdown of MCC resulted in accumulation of the inhibitor of kappa B alpha (IκBα) protein, encoded by NFKBIA, a first response gene specifically and rapidly regulated by NFκB pathway activation </plain></SENT>
<SENT sid="6" pm="."><plain>The MCC gene is methylated in up to 6/16 of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e>-associated tissue specimens, and myosin-10 and valosin-containing protein were identified as MCC-interacting proteins </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: These findings suggest that MCC modulates NFκB pathway signalling indirectly in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
</text></document>